BusinessTaconic Biosciences Announces Release of New Parkinson’s Disease Animal ModelBy Nasdaq OMXApr 25, 2017, 4:55 PM UTC
BusinessVoyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s DiseaseBy Nasdaq OMXApr 25, 2017, 11:02 AM UTC
BusinessAdamas Presents ADS-5102 Pooled Phase 3 Data Confirming Statistically Significant Reduction in Levodopa-Induced Dyskinesia and OFF Time in People with Parkinson’s DiseaseBy Nasdaq OMXApr 24, 2017, 1:06 PM UTC
BusinessAdamas Announces Oral and Poster Presentations of ADS-5102 Pooled Phase 3 Data at the 69th American Academy of Neurology Annual MeetingBy Nasdaq OMXApr 18, 2017, 4:08 PM UTC
BusinessAdamas Announces Data Presentation on ADS-5102 at the Academy of Managed Care Pharmacy 2017 Annual MeetingBy Nasdaq OMXMar 28, 2017, 5:38 PM UTC
BusinessAdamas to Present at the 16th Annual Needham Healthcare ConferenceBy Nasdaq OMXMar 28, 2017, 2:33 PM UTC
BusinessAdamas to Present at the 37th Annual Cowen Health Care ConferenceBy Nasdaq OMXMar 1, 2017, 7:44 PM UTC
BusinessAdamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016By Nasdaq OMXFeb 28, 2017, 9:06 PM UTC
